Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against the NCATS MIPE library collection: KHM11_PLB cell viability assay
Assay data:572 Active, 29 Activity ≤ 1 nM, 524 Activity ≤ 1 µM, 1912 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Depositor
Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against the NCATS MIPE library collection: Delta47_JCRB cell viability assay
Assay data:811 Active, 19 Activity ≤ 1 nM, 394 Activity ≤ 1 µM, 1912 Tested
Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Assay data:237 Active, 1947 Activity ≤ 1 µM, 141380 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
Primary qHTS for Inhibitors of N-terminal methyltransferase 1 (NTMT1): MTaseGlo Assay
Assay data:1477 Active, 244 Activity ≤ 1 µM, 58936 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Drug concentration at steady state in human at 0.5 to 4 mg, po BID/TID/QID after 6 hrs
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8)
Assay data:764 Active, 1 Activity ≤ 1 nM, 243 Activity ≤ 1 µM, 1910 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
BK Channel Variant Modulator Selectivity Assay
Assay data:286 Active, 904 Activity ≤ 1 nM, 951 Activity ≤ 1 µM, 951 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Cmax in healthy white human with SLCO1B1 521CC/CYP2C8*3/*3 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TC/CYP2C8*3/*3 combined genotype at 2 mg, po
Cmax in healthy white human with CYP2C8*3/*3 genotype at 2 mg, po
Cmax in healthy white human with CYP2C8*1/*3 genotype at 2 mg, po
Cmax in healthy white human with CYP2C8*1/*1 genotype at 2 mg, po
Cmax in healthy white human at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TT/CYP2C8*3/*3 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521CC/CYP2C8*1/*3 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TC/CYP2C8*1/*3 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TT/CYP2C8*1/*3 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TC/CYP2C8*1/*1 combined genotype at 2 mg, po
Cmax in healthy white human with SLCO1B1 521TT/CYP2C8*1/*1 combined genotype at 2 mg, po
insulin secretion from INS-1E cells in the presence of 0.1 mM glucose-IC50
Assay data:1 Active, 1 Activity ≤ 1 µM, 48 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Depositor
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on